[1]
“Early use of thrombopoietin receptor agonists (Tpo-Ras) in clinical practice: results from an Italian survey on behalf of the GIMEMA Working Group Anemia and Thrombocytopenia”, Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025041, Apr. 2025, doi: 10.4084/MJHID.2025.041.